Best Practices for Solving Complex Formulation Challenges While Maintaining Speed Through the Lifecycle
Complex formulations promise more targeted therapies, but there are roadblocks to commercialization.
Asma Patel, VP at Quotient Sciences, addresses the biggest challenges in complex small molecule formulation development and provides a roadmap for keeping speed to clinic while reducing risk.
Asma Patel, VP at Quotient Sciences, addresses the biggest challenges in complex small molecule formulation development and provides a roadmap for keeping speed to clinic while reducing risk.
Solubility and Bioavailability
Early characterization and enabling technologies help overcome poor solubility and variable absorption before they derail a program.
Tech Transfer and Scale-Up
Planning for scale-up from the first formulation decision reduces rework and protects timelines.
Batch Consistency
Robust process understanding and analytical control deliver consistent batches from clinical through commercial supply.
Download This White Paper
Biotechnology Media Insights
Continue to Biotechnology Media Insights to access this white paper.